Clinical trial

Atacicept in Combination With Rituximab in Subjects With Rheumatoid Arthritis (August III)

NCT00664521

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE2

Study timeline

Study start (unknown)2008-03-01Date precision: month

Registry last updated2016-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

RituximabBIOLOGICAL

AtaciceptDRUG · verified · RxNorm: atacicept

Placebo matched to ataciceptDRUG

Sponsors & collaborators

Merck KGaA, Darmstadt, Germanylead sponsor

Mapped research locations

ParisFrance1 StrasbourgFrance1 AmsterdamNetherlands1 StockholmSweden1 NiceFrance1 MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00664521 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.